NASDAQ:MDVL MedAvail (MDVL) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free MDVL Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$1.80▼$5.9552-Week Range N/AVolume245,100 shsAverage Volume261,432 shsMarket Capitalization$2.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get MedAvail alerts: Email Address Ad Crypto 101 MediaAltcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… Click here now to register for the event (FOR FREE!) About MedAvail Stock (NASDAQ:MDVL)MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.Read More Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here MDVL Stock News HeadlinesMarch 27, 2024 | americanbankingnews.comMedAvail (NASDAQ:MDVL) Trading Down 40.6%February 12, 2024 | msn.comUS Stocks Mixed; Trimble Issues Weak OutlookMarch 29, 2024 | DTI (Ad)the most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.February 12, 2024 | msn.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.33%February 9, 2024 | msn.comMedAvail Holdings Faces Nasdaq Delisting After BankruptcyFebruary 8, 2024 | msn.comWall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than ExpectedFebruary 8, 2024 | msn.comUS Futures Marginally Lower Ahead of Jobless Claims, Wholesale Trade DataFebruary 6, 2024 | msn.comU.S. shares higher at close of trade; Dow Jones Industrial Average up 0.37%March 29, 2024 | WealthPress (Ad)A lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. February 6, 2024 | msn.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.37%February 3, 2024 | msn.comMedAvail Holdings Files for Chapter 7 BankruptcyFebruary 2, 2024 | msn.comDow Falls 150 Points; US Economy Adds 353,000 Jobs In JanuaryJanuary 31, 2024 | investing.comMedavail Holdings Inc (MDVL)November 28, 2023 | finance.yahoo.comMedAvail Announces Agreement with New Orleans-Based St. Thomas Community Health Centers for Deployment of Two M4 MedCentersNovember 18, 2023 | morningstar.comMedAvail Holdings Inc Ordinary Shares MDVLNovember 18, 2023 | finanznachrichten.deMedAvail Holdings, Inc.: MedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-QNovember 17, 2023 | msn.comMedAvail receives non-compliance notice from NasdaqNovember 17, 2023 | benzinga.comMedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-QNovember 17, 2023 | finance.yahoo.comMedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-QNovember 17, 2023 | finance.yahoo.comMedAvail Announces Agreement with ASP Cares for Deployment of Ten M4 MedCentersNovember 10, 2023 | msn.comMDVL, BACK and FTEL are among mid-day moversAugust 30, 2023 | finance.yahoo.comMedAvail to Participate in H.C. Wainwright 25th Annual Global Investment ConferenceAugust 16, 2023 | finance.yahoo.comPotential Upside For MedAvail Holdings, Inc. (NASDAQ:MDVL) Not Without RiskAugust 15, 2023 | finanznachrichten.deMedAvail Holdings, Inc.: MedAvail Reports Second Quarter 2023 Financial ResultsAugust 14, 2023 | finance.yahoo.comMedAvail Reports Second Quarter 2023 Financial ResultsAugust 4, 2023 | finance.yahoo.comMedAvail Announces Agreement with Dallas-Based Oak Lawn Pharmacy for Deployment of Ten M4 MedCentersAugust 1, 2023 | finanznachrichten.deMedAvail Holdings, Inc.: MedAvail Announces 1-for-50 Reverse Stock SplitSee More Headlines Receive MDVL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2021Today3/28/2024Next Earnings (Estimated)4/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drug stores & proprietary stores Sub-IndustryN/A Current SymbolNASDAQ:MDVL CUSIPN/A CIK1402479 Webwww.medavail.com Phone(905) 812-0023Fax973-348-5707Employees279Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($28.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-47,620,000.00 Net Margins-192.97% Pretax MarginN/A Return on Equity-218.10% Return on Assets-103.45% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$43.33 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$13.01 per share Price / BookN/AMiscellaneous Outstanding Shares1,614,000Free Float1,590,000Market Cap$2.91 million OptionableNo Data Beta0.76 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Mark Doerr RPh (Age 54)CEO, President & Director Comp: $424.42kMs. Ramona Seabaugh (Age 55)CFO, Treasurer & Secretary Comp: $367.94kEmilia KericSenior VP & General CounselMs. Joan O'RourkePresident of SpotRxMr. Brian SchlerfCorporate ControllerKey CompetitorsNanoString TechnologiesNASDAQ:NSTGQAraviveNASDAQ:ARAVEloxx PharmaceuticalsNASDAQ:ELOXAssureNASDAQ:IONMNantHealthNASDAQ:NHView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Sold 6,990 shares on 3/11/2024Ownership: 0.869%Ramona SeabaughSold 303 sharesTotal: $1,727.10 ($5.70/share)View All Insider TransactionsView All Institutional Transactions MDVL Stock Analysis - Frequently Asked Questions When is MedAvail's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, April 11th 2024. View our MDVL earnings forecast. How were MedAvail's earnings last quarter? MedAvail Holdings, Inc. (NASDAQ:MDVL) issued its quarterly earnings results on Monday, November, 8th. The company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.32) by $0.02. The company had revenue of $5.79 million for the quarter. MedAvail had a negative trailing twelve-month return on equity of 218.10% and a negative net margin of 192.97%. During the same quarter last year, the firm earned ($0.84) earnings per share. Who are MedAvail's major shareholders? MedAvail's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (0.87%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Mark Edward Doerr, Ramona Seabaugh and Wtt-Medavail Ltd Abg. View institutional ownership trends. How do I buy shares of MedAvail? Shares of MDVL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MDVL) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedAvail Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.